Fig. 5.

Identification of the independent prognostic factors in the training and validation group. A Univariate Cox analyses of the signature-based risk score and clinicopathological parameters in the training group. B Multivariate Cox analyses of the signature-based risk score and clinicopathological parameters in the training group. C Univariate Cox analyses of the signature-based risk score and clinicopathological parameters in the validation group. D Multivariate Cox analyses of the signature-based risk score and clinicopathological parameters in the validation group. E Prognostic nomogram for melanoma patients. F–G Calibration curves for the nomogram at 1-, and 3-year